Clinical Trials Directory

Trials / Sponsors / GL Pharm Tech Corporation

GL Pharm Tech Corporation

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
UnknownPhase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease
Dry Eye Syndromes
Phase 22021-04-01
CompletedA Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Sin
Dry Eye Syndromes
Phase 12019-09-26
UnknownThe Pharmacokinetics of GLA5PR Tablet According to the Renal Function
Neuropathic Pain
Phase 12019-09-17
CompletedPharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)
Healthy
Phase 12019-05-02
CompletedPharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers
Healthy
Phase 12019-01-02
CompletedBioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg
Healthy
Phase 12016-11-01
CompletedBioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg
Healthy
Phase 12016-11-01
CompletedA Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of
Healthy
Phase 12014-10-01
CompletedStudy to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients W
Benign Prostatic Hyperplasia
Phase 32014-03-01
CompletedPK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Heal
Healthy
Phase 12014-02-01
CompletedA Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS-NF1 Tablet 150mg With Immediate Release
Healthy
Phase 12013-10-01
CompletedA PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers
Healthy
Phase 12013-08-01
CompletedA Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacok
Healthy
Phase 12013-04-01
CompletedA Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release For
Healthy
Phase 12012-10-01
CompletedA Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab.
Healthy
Phase 12012-03-01